OR WAIT null SECS
Sarath Raju, MD, from Johns Hopkins University School of Medicine.
May 27, 2026
Video
At ATS 2026, Sarath Raju, MD, discussed retrospective data linking SGLT2 inhibitor use to reduced 30-day readmissions in patients hospitalized for AE-COPD and diabetes.